本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

再生元制药公司

585.29
-13.4700-2.25%
成交量:72.78万
成交额:4.27亿
市值:632.11亿
市盈率:14.84
高:593.94
开:589.77
低:578.50
收:598.76
数据加载中...
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/02

重要事件披露

Form 8-K - Current report
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities